Regen-Cov is a combination of two monoclonal antibodies, known as casirivimab and imdevimab. Antibodies are immune-system proteins that disable pathogens by locking specifically onto them. Both casirivimab and imdevimab bind to different sites on the coronavirus’s “spike” protein, preventing the virus from infecting cells. Using two antibodies instead of one reduces the risk of the virus evolving resistance to the treatment. Antibody therapy improves the survival of patients with covid-19 and offers renewed hope for the treatment of those most seriously ill with the disease. What is your thought on using Antibody therapy to help fight Covid-19 ?
